Nexentis Technologies Inc stock is traded at $2.06, with a volume of 3,787. It is down -10.43% in the last 24 hours and down -45.49% over the past month. Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Previous Close:
$2.30
Open:
$2.20
24h Volume:
3,787
Relative Volume:
0.05
Market Cap:
$978.71K
Revenue:
$2,000
Net Income/Loss:
-$12.72M
P/E Ratio:
-
EPS:
-$71.81
Net Cash Flow:
-$3.91M
1W Performance:
-14.43%
1M Performance:
-45.49%
6M Performance:
-91.10%
1Y Performance:
0.00%
1-Day Range:
$2.02$2.20
1-Week Range:
$2.02$2.77
52-Week Range:
$2.02$119.00
Nexentis Technologies Inc Stock (NXTS) Company Profile
Name
Nexentis Technologies IncSector
Basic MaterialsIndustry
Agricultural InputsPhone
972544561349Address
156 FIFTH AVENUE 10TH FLOOR, NEW YORK, IsraelMarket Cap
Revenue
Net Income
Cash Flow
EPS